Logo of Excellos

Excellos

Excellos Labs, LLC is the San Diego operation of OrganaBio, LLC, formed when OrganaBio acquired the operating assets of Excellos, Inc. in May 2026. Founded in 2021 as an independent spinout of the San Diego Blood Bank, Excellos built a purpose-built, full-service cell therapy facility in downtown San Diego featuring five ISO 7 cGMP cleanroom suites. The site supports autologous and allogeneic cell therapy manufacturing, apheresis donor cell collection, cell isolation and enrichment, transduction, expansion, fill/finish, and cryopreservation. The core Excellos team was retained through the transaction, and existing customer programs continue under Excellos Labs as part of OrganaBio’s bicoastal platform, operating under a single quality system across all sites. For more information, visit www.excelloslabs.com 

Content by Excellos

Abstract illustration of cells.
| 2 min read
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Researcher examining a multiwell plate alongside cell culture dishes in a laboratory.
Explore how direct cell lysis can reduce sample preparation steps and support efficient gene expression analysis by RT-qPCR.
Abstract rainbow-colored beams of light spreading across a dark background.
Compare fluorochromes based on resolution, spillover, antigen expression, and other factors that can affect panel performance.
Illustration of multiple glowing blue and purple spherical cells against a dark blue background.
As researchers embrace more complex cellular models, high-content analysis brings new opportunities and challenges to drug discovery.